ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

October 21, 1977

FDA Approves Generic Capecitabine

September 20, 2013

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

January 6, 2012

Funding opportunities listed.

April 30, 2004

Nixon National Cancer Conference Kicks Off

December 8, 2021